Cardax Pharma

company

About

Cardax Pharma offers small molecule therapies for unmet medical needs such as hepatitis, arthritis, cardiovascular diseases, and more.

  • 1 - 10

Details

Last Funding Type
Series Unknown
Industries
Biopharma,Biotechnology,Health Care,Pharmaceutical
Founded date
Jan 1, 2006
Number Of Employee
1 - 10
Operating Status
Active

Cardax Pharmaceuticals develops proprietary small molecule therapies for large unmet medical needs where oxidative stress and inflammation play important causative roles—including dyslipidemia, metabolic disease, arthritis, cardiovascular disease, hepatitis, macular degeneration, and many others.

Most anti-inflammatory drugs have significant safety and side effect issues that limit their utility. In contrast, the company’s proprietary, synthetic, natural compound derivatives represent a novel treatment approach that offers robust efficacy combined with exceptional safety, oral bioavailability, and tissue selectivity.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
Cardax Pharma has raised a total of — in funding over 2 rounds. Their latest funding was raised on Mar 31, 2004 from a Series Unknown round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Mar 31, 2004 Series Unknown 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
Cardax Pharma is funded by 1 investors. Advantage Capital are the most recent investors.
Investor Name Lead Investor Funding Round
Advantage Capital Series Unknown